Comprehensive evaluation of the clinical utility of plasma EGFR test in non-small cell lung cancer patients with acquired resistance to first-line EGFR inhibitors

BACKGROUND: Plasma epidermal growth factor receptor (EGFR) mutation tests are widely used when non-small cell lung cancer (NSCLC) patients acquire resistance to EGFR inhibitors. We comprehensively evaluated the clinical utility of plasma EGFR test. METHODS: We screened NSCLC patients who had a plasm...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hongsik, Jung, Hyun Ae, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil, Sun, Jong-Mu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947405/
https://www.ncbi.nlm.nih.gov/pubmed/33718029
http://dx.doi.org/10.21037/tlcr-20-1128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947405/
https://www.ncbi.nlm.nih.gov/pubmed/33718029
http://dx.doi.org/10.21037/tlcr-20-1128

Ejemplares similares